ALXA Insider Trading Activity and SEC Form 4 Filings
ALXA insider trading summary
No open-market insider purchases or sales of Alexza Pharmaceuticals Inc. (ALXA) have been reported on SEC Form 4 in the past 12 months.
Latest ALXA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 21, 2016 | Grupo Ferrer Internacional, S.A. | 10% Owner | Buy | $17.5M (19,465,714 @ $0.90) |
| Jun 21, 2016 | Sergio Ferrer-Salat | 10% Owner | Buy | $17.5M (19,465,714 @ $0.90) |
| Sep 28, 2015 | Grupo Ferrer Internacional, S.A. | 10% Owner | Buy | $0 (125,000 @ $0.00) |
| Sep 6, 2013 | Gordon Ringold | Director | Buy | $48K (10,000 @ $4.77) |
| Jul 26, 2013 | Thomas Braxton King | Pres & CEO | Buy | $11K (2,420 @ $4.49) |
| Jul 25, 2013 | Thomas Braxton King | Pres & CEO | Buy | $57K (12,580 @ $4.50) |
| Jul 24, 2013 | Thomas Braxton King | Pres & CEO | Buy | $112K (25,000 @ $4.48) |
| Jan 18, 2013 | Lansdowne Partners Austria Gmbh | 10% Owner | Sell | $119K (25,000 @ $4.75) |
| Jan 17, 2013 | Lansdowne Partners Austria Gmbh | 10% Owner | Sell | $475K (100,000 @ $4.75) |
| Dec 27, 2012 | Lansdowne Partners Austria Gmbh | 10% Owner | Buy | $212K (43,600 @ $4.86) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.